Aura Biosciences, Inc. (AURA)
About Aura Biosciences, Inc.
Aura Biosciences Inc is a clinical-stage biotechnology company developing precision immunotherapies to treat a range of solid tumors designed to preserve the function of organs afflicted with cancer. Its candidate bel-sar is in late-stage clinical development for the treatment of patients with primary choroidal melanoma, and other ocular oncology indications as well as in early-stage clinical development in bladder cancer. The Company views its operations and manages its business in one operating segment operating exclusively in the United States.
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Net income
- -$106.2M
- Total assets
- $169.4M
- Market cap
- $685.5M
Source: SEC EDGAR · updated Jun 7, 2026
Revenue & profit trend
Financial statements
Income statement
- Operating income
- -$112.8M
- Income tax
- $108.0K
- Net income
- -$106.2M
- EPS (basic)
- $-1.76
- EPS (diluted)
- $-1.76
Balance sheet
- Total assets
- $169.4M
- Current assets
- $149.7M
- Total liabilities
- $32.5M
- Current liabilities
- $18.4M
- Shareholders’ equity
- $136.9M
Cash flow
- Operating cash flow
- -$84.7M
- Investing cash flow
- $35.6M
- Financing cash flow
- $77.2M
- Net cash flow
- $28.0M
Statements via Polygon.io (SEC filings)
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Market cap
- $685.5M
- EPS (diluted)
- $-1.76
- Shares outstanding
- 97.2M
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
- IPO date
- Oct 29, 2021
Aura Biosciences, Inc. (AURA) Stock Price
- Reported a net loss of $106.2M.
- Trading 21% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Aura Biosciences, Inc..
Write a review
News about Aura Biosciences, Inc.
News & sentiment via Polygon.io
Aura Biosciences, Inc.: frequently asked questions
Is Aura Biosciences, Inc. an American company?
Aura Biosciences, Inc. is a US-based company headquartered in Boston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Aura Biosciences, Inc. headquartered?
Aura Biosciences, Inc. is headquartered in Boston, Massachusetts, United States.
Is Aura Biosciences, Inc. publicly traded?
Yes — Aura Biosciences, Inc. is a publicly traded company. Its stock trades under the ticker symbol AURA on the NASDAQ.
What does Aura Biosciences, Inc. do?
Aura Biosciences, Inc. is an American Pharmaceuticals company in the Health & Beauty sector.
